Strand Therapeutics engineers programmable mRNA therapies designed to precisely target and destroy cancer cells while sparing healthy tissue. Their synthetic biology platform creates self-amplifying treatments that activate only within tumors, reducing side effects. Oncologists benefit from enhanced precision, while patients gain access to potentially safer, more effective immunotherapies against solid tumors.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends